FDA Special Protocol Assessment (SPA) For Expanded Indication Of LibiGel� In FSD For Female Sexual Dysfuntion BioSante Pharmaceuticals, Inc. (NASDAQ: BPAX) announced today that it successfully has completed and reached an additional agreement with the U.S. Food and Drug Administration (FDA) under the Special Protocol Assessment (SPA) process for its LibiGel (transdermal testosterone gel) program in the treatment of female sexual dysfunction (FSD), specifically, hypoactive sexual desire disorder (HSDD) in "naturally" menopausal women.
Source: www.medicalnewstoday.comOne In Four Pregnant Women Do Not Feel Well Informed By Their Gynaecologist A survey carried out among 250 pregnant women showed that 24% of them do not feel adequately informed by their gynaecologist, and almost half do not take part in any prenatal course. The study, prepared by the Head of the Obstetrics Department at the Hospital Clínico San Carlos in Madrid, Miguel Ángel Herráiz, also showed that 80% of those surveyed prefer a "medicalised" birth, with epidural anaesthesia, to a natural birth.
Source: www.medicalnewstoday.comPrevalence And Characteristics Of Lower Urinary Tract Symptoms In Men Aged Over 80 UroToday.com - Although previous studies have examined lower urinary tract symptoms in older male populations, this is, to our knowledge, the first in-detail analysis of LUTS in community-dwelling men aged over 80 years.
Source: www.medicalnewstoday.com
# posted by Network @ 10:01 AM
